|
CAMBRIDGE
ANTIBODY TECHNOLOGY
|
LONDON STOCK EXCHANGE
Cambridge
Antibody Technology (CAT) is a world leading company in the discovery and
development of human monoclonal antibody therapeutics.
CAT
was established in 1990 and listed on the London Stock Exchange in 1997.
In June 2001, CAT completed a listing on the US NASDAQ National Market.
Based near Cambridge, UK, the Company currently employs around 290 staff.
|
